发明名称 HEMIFUMARATE SALT OF 1-[4-[1-(4-CYCLOHEXYL-3 -TRIFLUOROMETHYL-BENZYLOXYIMINO)-ETHYL]-2-ETHYL-BENZYL]-AZETIDINE-3-CARBOXYLIC ACID FOR USE IN THE TREATMENT OF LYMPHOCYTE MEDIATED DISEASES
摘要 This invention relates to a hemifumarate salt of 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzyloxyimino]-ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic acid (Compound I) for use in medical treatment and to pharmaceutical compositions comprising this salt.
申请公布号 EP2676953(B1) 申请公布日期 2017.03.22
申请号 EP20130177190 申请日期 2009.12.16
申请人 Novartis AG 发明人 Ciszewski, Lech;De La Cruz, Marilyn;Karpinski, Piotr H.;Mutz, Michael;Riegert, Christian;Vogel, Caspar;Sschneeberger, Ricardo
分类号 C07D205/04;A61K31/397;A61P35/00;A61P37/00 主分类号 C07D205/04
代理机构 代理人
主权项
地址